Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies

P Magalhães, HA Lashuel - npj Parkinson's Disease, 2022 - nature.com
Abstract Parkinson's disease (PD), the second most common progressive
neurodegenerative disease, develops and progresses for 10–15 years before the clinical …

[HTML][HTML] Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis

ME Johnson, B Stecher, V Labrie, L Brundin… - Trends in …, 2019 - cell.com
We hypothesize that Parkinson's disease (PD) pathogenesis can be divided into three
temporal phases. During the first phase,'triggers', such as viral infections or environmental …

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism

M Barichella, M Severgnini, R Cilia… - Movement …, 2019 - Wiley Online Library
Background Although several studies have suggested that abnormalities in gut microbiota
may play a critical role in the pathogenesis of PD, data are still extremely heterogeneous …

Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977–2014

M Villumsen, S Aznar, B Pakkenberg, T Jess, T Brudek - Gut, 2019 - gut.bmj.com
Objective Intestinal inflammation has been suggested to play a role in development of
Parkinson's disease (PD) and multiple system atrophy (MSA). To test the hypothesis that IBD …

Alpha-synuclein as a biomarker of Parkinson's disease: good, but not good enough

U Ganguly, S Singh, S Pal, S Prasad… - Frontiers in aging …, 2021 - frontiersin.org
Parkinson's disease (PD) is the second most common neurodegenerative disorder of the
elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed …

Parkinson's disease biomarkers based on α‐synuclein

M Fayyad, S Salim, N Majbour, D Erskine… - Journal of …, 2019 - Wiley Online Library
Parkinson's disease is the second most common neurodegenerative disorder after
Alzheimer's disease and is estimated to affect approximately 1–4% of individuals aged over …

Desulfovibrio bacteria enhance alpha-synuclein aggregation in a Caenorhabditis elegans model of Parkinson's disease

VA Huynh, TM Takala, KE Murros, B Diwedi… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction The aggregation of the neuronal protein alpha-synuclein (alpha-syn) is a key
feature in the pathology of Parkinson's disease (PD). Alpha-syn aggregation has been …

Association of NO2 and other air pollution exposures with the risk of Parkinson disease

S Jo, YJ Kim, KW Park, YS Hwang, SH Lee… - JAMA …, 2021 - jamanetwork.com
Importance The development of Parkinson disease (PD) may be promoted by exposure to
air pollution. Objective To investigate the potential association between exposure to …

Does Parkinson's disease start in the gut?

A Lionnet, L Leclair-Visonneau, M Neunlist… - Acta …, 2018 - Springer
Parkinson's disease (PD) is pathologically characterized by the presence of intraneuronal
inclusions, termed Lewy bodies and Lewy neurites, whose main component is alpha …

Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut–brain axis

SJ Chen, CH Lin - Journal of biomedical science, 2022 - Springer
Parkinson's disease (PD) is the second most common neurodegenerative disease attributed
to the synergistic effects of genetic risk and environmental stimuli. Although PD is …